Skip to main content
Top
Published in: Tumor Biology 4/2013

Open Access 01-08-2013 | Research Article

Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment

Authors: Joanna Jakubowicz-Gil, Ewa Langner, Dorota Bądziul, Iwona Wertel, Wojciech Rzeski

Published in: Tumor Biology | Issue 4/2013

Login to get access

Abstract

Glioblastoma multiforme is the most aggressive primary brain tumour. At the cellular and molecular levels, several mechanisms responsible for apoptosis or autophagy induction are blocked. Identification of molecular targets stimulating cells to initiate programmed cell death should be performed for therapeutic purposes. A promising solution is the combination of temozolomide and quercetin. The aim of our study was to evaluate the effect of both drugs, applied alone and in combinations, on apoptosis and autophagy induction in human glioblastoma multiforme T98G cells. Our results clearly indicate that quercetin and temozolomide induce apoptosis very significantly, having no effect on autophagy induction. At the molecular level, it was correlated with caspase 3 and 9 activation, cytochrome c release from the mitochondrium and a decrease in the mitochondrial membrane potential. Both drugs are also potent Hsp27 and Hsp72 inhibitors. This suggests that the apoptotic signal goes through an internal pathway. Increased expression of caspase 12 and the presence of several granules in the cytoplasm after temozolomide treatment with or without quercetin preceding appearance of apoptosis may suggest that apoptosis is initiated by ER stress. Additionally, it was accompanied by changes in the nuclear morphology from circular to ‘croissant like’.
Literature
1.
go back to reference Kleihues P et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–25.PubMed Kleihues P et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–25.PubMed
2.
go back to reference Omuro AM, Faivre S, Raymond E. Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther. 2007;6:1909–19.PubMedCrossRef Omuro AM, Faivre S, Raymond E. Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther. 2007;6:1909–19.PubMedCrossRef
3.
go back to reference Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479–89.PubMed Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479–89.PubMed
4.
go back to reference Ghobrial IM, Witzig TE, Adjei A. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 2005;5:178–94.CrossRef Ghobrial IM, Witzig TE, Adjei A. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 2005;5:178–94.CrossRef
5.
go back to reference Lefranc F, Facchini V, Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on gliomas. Oncologist. 2007;12:1395–403.PubMedCrossRef Lefranc F, Facchini V, Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on gliomas. Oncologist. 2007;12:1395–403.PubMedCrossRef
6.
go back to reference Uzzman M, Keller G, Germano IM. Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells. J Neurosurg. 2007;106:646–51.CrossRef Uzzman M, Keller G, Germano IM. Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells. J Neurosurg. 2007;106:646–51.CrossRef
7.
go back to reference Kanzawa T, Germano IM, Komata T, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004;11:448–57.PubMedCrossRef Kanzawa T, Germano IM, Komata T, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004;11:448–57.PubMedCrossRef
8.
go back to reference Tentori L, Graziani G. Recent approaches to improve the antitumor efficacy of temozolomide. Curr Med Chem. 2009;16:254–7.CrossRef Tentori L, Graziani G. Recent approaches to improve the antitumor efficacy of temozolomide. Curr Med Chem. 2009;16:254–7.CrossRef
9.
go back to reference Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, et al. Apoptosis in malignant gliomas cells triggered by temozolomide-induced DNA lesion O6-methyguanine. Oncogene. 2007;26:186–97.PubMedCrossRef Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, et al. Apoptosis in malignant gliomas cells triggered by temozolomide-induced DNA lesion O6-methyguanine. Oncogene. 2007;26:186–97.PubMedCrossRef
10.
go back to reference Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem. 2007;18:427–42.PubMedCrossRef Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem. 2007;18:427–42.PubMedCrossRef
11.
go back to reference Russo GL. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol. 2007;22:317–20. Russo GL. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol. 2007;22:317–20.
12.
go back to reference Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, et al. Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs. 2006;17:663–71.PubMedCrossRef Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, et al. Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs. 2006;17:663–71.PubMedCrossRef
13.
go back to reference Schültke E, Kamencic H, Zhao M, Tian GF, Baker AJ, Griebel RW, et al. Neuroprotection following fluid percussion brain trauma: a pilot study using quercetin. J Neurotrauma. 2005;22:1475–84.PubMedCrossRef Schültke E, Kamencic H, Zhao M, Tian GF, Baker AJ, Griebel RW, et al. Neuroprotection following fluid percussion brain trauma: a pilot study using quercetin. J Neurotrauma. 2005;22:1475–84.PubMedCrossRef
14.
go back to reference Hosokawa N, Hirayoshi K, Kudo H, Takechi H, Aoike A, Kawai K, et al. Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol Cell Biol. 1992;12:3490–8.PubMed Hosokawa N, Hirayoshi K, Kudo H, Takechi H, Aoike A, Kawai K, et al. Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol Cell Biol. 1992;12:3490–8.PubMed
15.
go back to reference Jakubowicz-Gil J, Langner E, Rzeski W. Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells. Pharmacol Rep. 2011;63:403–16.PubMed Jakubowicz-Gil J, Langner E, Rzeski W. Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells. Pharmacol Rep. 2011;63:403–16.PubMed
16.
go back to reference Jakubowicz-Gil J, Langner E, Wertel I, Piersiak T, Rzeski W. Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. Chem Biol Inter. 2010;188:190–203.CrossRef Jakubowicz-Gil J, Langner E, Wertel I, Piersiak T, Rzeski W. Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. Chem Biol Inter. 2010;188:190–203.CrossRef
17.
go back to reference Jankowska A, Skonieczna D, Rommerts FFC, Warchoł JB. Investigations on apoptosis in Leydig cells cultured in vitro. Folia Histochem Cytobiol. 1997;33:99–110. Jankowska A, Skonieczna D, Rommerts FFC, Warchoł JB. Investigations on apoptosis in Leydig cells cultured in vitro. Folia Histochem Cytobiol. 1997;33:99–110.
18.
go back to reference Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 2005;65:3336–46.PubMed Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 2005;65:3336–46.PubMed
19.
go back to reference Kim EJ, Choi CH, Park JY, Kang SK, Kim YK. Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res. 2008;33:971–9.PubMedCrossRef Kim EJ, Choi CH, Park JY, Kang SK, Kim YK. Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res. 2008;33:971–9.PubMedCrossRef
20.
go back to reference Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.PubMedCrossRef Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.PubMedCrossRef
21.
go back to reference Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5.PubMedCrossRef Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5.PubMedCrossRef
22.
go back to reference Nafe R, Franz K, Schlote W, Schneider B. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas. Clin Cancer Res. 2005;11:2141–8.PubMedCrossRef Nafe R, Franz K, Schlote W, Schneider B. Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas. Clin Cancer Res. 2005;11:2141–8.PubMedCrossRef
23.
go back to reference Nafe R, Franz K, Schlote W, Schneider B. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time. Oncol Rep. 2006;16:555–62.PubMed Nafe R, Franz K, Schlote W, Schneider B. The morphology of perinecrotic tumor cell nuclei in glioblastomas shows a significant relationship with survival time. Oncol Rep. 2006;16:555–62.PubMed
24.
go back to reference Terasaki M, Reese TS. Characterization of endoplasmic reticulum by co-localization of BiP and dicarbocyanine dyes. J Cell Sci. 1992;101:315–22.PubMed Terasaki M, Reese TS. Characterization of endoplasmic reticulum by co-localization of BiP and dicarbocyanine dyes. J Cell Sci. 1992;101:315–22.PubMed
25.
go back to reference Lefranc F, Kiss R. Autophagy, the Trojan horse to combat glioblastomas. Neurosurg Focus. 2006;20:E7.PubMedCrossRef Lefranc F, Kiss R. Autophagy, the Trojan horse to combat glioblastomas. Neurosurg Focus. 2006;20:E7.PubMedCrossRef
26.
go back to reference Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH, Chen TM, et al. Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS One. 2012;7:e38706.PubMedCrossRef Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH, Chen TM, et al. Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS One. 2012;7:e38706.PubMedCrossRef
27.
go back to reference Garcia-Arencibia M, Hochfeld WE, Toh PPC, Rubinsztein DC. Autophagy, a guardian against neurodegeneration. Semin Cell Dev Biol. 2010;21:691–8.PubMedCrossRef Garcia-Arencibia M, Hochfeld WE, Toh PPC, Rubinsztein DC. Autophagy, a guardian against neurodegeneration. Semin Cell Dev Biol. 2010;21:691–8.PubMedCrossRef
28.
go back to reference Wang J. Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy. 2008;4:947–8.PubMed Wang J. Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy. 2008;4:947–8.PubMed
29.
go back to reference Luo S, Rubinsztein DC. Apoptosis blocks Beclin 1-dependent autophagosome synthesis—an effect reduced by Bcl-xL. Cell Death Differ. 2010;17:268–77.PubMedCrossRef Luo S, Rubinsztein DC. Apoptosis blocks Beclin 1-dependent autophagosome synthesis—an effect reduced by Bcl-xL. Cell Death Differ. 2010;17:268–77.PubMedCrossRef
30.
go back to reference Pirtoli L, Cevenini G, Tini P, Vannini M, Oliveri G, Marsisli S, et al. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy. 2009;5:930–6.PubMedCrossRef Pirtoli L, Cevenini G, Tini P, Vannini M, Oliveri G, Marsisli S, et al. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy. 2009;5:930–6.PubMedCrossRef
31.
go back to reference Rodriguez-Gonzales A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation. Cancer Res. 2006;68:2557–60.CrossRef Rodriguez-Gonzales A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation. Cancer Res. 2006;68:2557–60.CrossRef
32.
go back to reference Gupta S, Deepti A, Deegan S, Lisbona F, Hetz C, Samali A. Hsp72 protects cells from ER stress-induced apoptosis via enhancement of ire1α-xbp1 signaling through a physical interaction. PLoS Biol. 2010;8:e1000410.PubMedCrossRef Gupta S, Deepti A, Deegan S, Lisbona F, Hetz C, Samali A. Hsp72 protects cells from ER stress-induced apoptosis via enhancement of ire1α-xbp1 signaling through a physical interaction. PLoS Biol. 2010;8:e1000410.PubMedCrossRef
33.
go back to reference Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, et al. Caspase 12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000;403:98–103.PubMedCrossRef Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, et al. Caspase 12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000;403:98–103.PubMedCrossRef
34.
go back to reference Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, et al. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem. 2002;14:1836–42. Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, et al. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem. 2002;14:1836–42.
35.
go back to reference Shiraishi H, Okamoto H, Yoshimura A, Yoshida H. ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1. J Cell Sci. 2006;119:3958–66.PubMedCrossRef Shiraishi H, Okamoto H, Yoshimura A, Yoshida H. ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1. J Cell Sci. 2006;119:3958–66.PubMedCrossRef
36.
go back to reference Mauro C, Crescenzi E, De Mattia R, Pacifico F, Mellone S, Salzano S, et al. Central role of the scaffold protein tumor necrosis factor receptor-associated factor 2 in regulating endoplasmic reticulum stress-induced apoptosis. J Biol Chem. 2006;281:2631–8.PubMedCrossRef Mauro C, Crescenzi E, De Mattia R, Pacifico F, Mellone S, Salzano S, et al. Central role of the scaffold protein tumor necrosis factor receptor-associated factor 2 in regulating endoplasmic reticulum stress-induced apoptosis. J Biol Chem. 2006;281:2631–8.PubMedCrossRef
37.
go back to reference Stetler RA, Gan Y, Zhang W, Liou AK, Gao Y, Cao G, et al. Heat shock proteins: cellular and molecular mechanisms in the CNS. Prog Neurobiol. 2010;92:184–211.PubMedCrossRef Stetler RA, Gan Y, Zhang W, Liou AK, Gao Y, Cao G, et al. Heat shock proteins: cellular and molecular mechanisms in the CNS. Prog Neurobiol. 2010;92:184–211.PubMedCrossRef
38.
go back to reference Turturici G, Sconzo G, Geraci F. Hsp70 and its molecular role in nervous system diseases. Biochem Res Int. 2011;2011:618127.PubMed Turturici G, Sconzo G, Geraci F. Hsp70 and its molecular role in nervous system diseases. Biochem Res Int. 2011;2011:618127.PubMed
39.
go back to reference Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. Heat shock proteins 27 and Hsp 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 2006;5:2592–601.PubMedCrossRef Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. Heat shock proteins 27 and Hsp 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 2006;5:2592–601.PubMedCrossRef
40.
go back to reference Sreedhar AS, Csermley P. Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy. A comprehensive review. Pharm Ther. 2007;101:2227–57. Sreedhar AS, Csermley P. Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy. A comprehensive review. Pharm Ther. 2007;101:2227–57.
41.
go back to reference Graner MW, Cumming RI, Binger DD. The heat shock response and chaperone/heat shock proteins in brain tumors: surface expression, release and possible immune consequences. J Neurosci. 2007;27:11214–27.PubMedCrossRef Graner MW, Cumming RI, Binger DD. The heat shock response and chaperone/heat shock proteins in brain tumors: surface expression, release and possible immune consequences. J Neurosci. 2007;27:11214–27.PubMedCrossRef
Metadata
Title
Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment
Authors
Joanna Jakubowicz-Gil
Ewa Langner
Dorota Bądziul
Iwona Wertel
Wojciech Rzeski
Publication date
01-08-2013
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0785-0

Other articles of this Issue 4/2013

Tumor Biology 4/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine